NCT03647982View on ClinicalTrials.gov

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

October 20, 2018

Study Completion Date

November 20, 2018

Conditions
Anhidrotic AreaHyperhidrosis
Interventions
DRUG

Meditoxin

injection of MEDITOXIN into the intradermal of each contralateral upper back in equal doses

DRUG

Botox

injection of Botox into the intradermal of each contralateral upper back in equal doses

Trial Locations (1)

130-709

Catholic University St. Paul Hospital, Seoul

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT03647982 - Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers | Biotech Hunter | Biotech Hunter